Protalix BioTherapeutics
PLX
#8762
Rank
โ‚ฌ0.14 B
Marketcap
1,77ย โ‚ฌ
Share price
1.73%
Change (1 day)
-17.63%
Change (1 year)

Market capitalization of Protalix BioTherapeutics (PLX)

Market cap: โ‚ฌ0.14 Billion

As of January 2026 Protalix BioTherapeutics has a market cap of โ‚ฌ0.14 Billion. This makes Protalix BioTherapeutics the world's 8762th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Protalix BioTherapeutics from 1997 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ0.14 B14.57%
2025โ‚ฌ0.12 B-4.31%
2024โ‚ฌ0.12 B10.24%
2023โ‚ฌ0.11 B81.53%
2022โ‚ฌ64.7 M93.41%
2021โ‚ฌ33.45 M-65.99%
2020โ‚ฌ98.38 M126.45%
2019โ‚ฌ43.44 M7.7%
2018โ‚ฌ40.33 M-47.61%
2017โ‚ฌ76.99 M47.04%
2016โ‚ฌ52.36 M-43.75%
2015โ‚ฌ93.1 M-34.26%
2014โ‚ฌ0.14 B-46.22%
2013โ‚ฌ0.26 B-28.21%
2012โ‚ฌ0.36 B12.85%
2011โ‚ฌ0.32 B-46.41%
2010โ‚ฌ0.60 B62.38%
2009โ‚ฌ0.37 B273.77%
2008โ‚ฌ99.93 M-43.36%
2007โ‚ฌ0.17 B-77.43%
2006โ‚ฌ0.78 B3637.85%
2005โ‚ฌ20.91 M4766.74%
2004โ‚ฌ0.42 M-53.59%
2003โ‚ฌ0.92 M201.93%
2002โ‚ฌ0.3 M-59.59%
2001โ‚ฌ0.75 M-2.76%
2000โ‚ฌ0.78 M-1.56%
1999โ‚ฌ0.79 M-83.53%
1998โ‚ฌ4.81 M-75.09%
1997โ‚ฌ19.33 M

End of Day market cap according to different sources

On Jan 13th, 2026 the market cap of Protalix BioTherapeutics was reported to be:

โ‚ฌ0.13 Billion
by Nasdaq info icon info icon
โ‚ฌ0.13 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Amicus Therapeutics
FOLD
โ‚ฌ3.81 B 2,587.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚ฌ11.58 B 8,062.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ124.83 B 87,835.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ32.12 B 22,527.63%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel